alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### § 162.1901 Medicaid pharmacy subrogation transaction.

The Medicaid pharmacy subrogation transaction is the transmission of a claim from a Medicaid agency to a payer for the purpose of seeking reimbursement from the responsible health plan for a pharmacy claim the State has paid on behalf of a Medicaid recipient.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Office of the Secretary of Defense

# AGENCY:

Department of Defense, Advisory Group on Electron Devices.

# ACTION:

Notice. 

# SUMMARY:

The DoD Advisory Group on Electron Devices (AGED) announces a closed session meeting.

# DATES:

The meeting will be held at 0900, Tuesday, December 5, 2006.

# ADDRESSES:

The meeting will be held at ITS Noesis Business Unit, 4100 N. Fairfax Drive, Suite 800, Arlington, VA 22203.

      ( print page 69205)    

# FOR FURTHER INFORMATION CONTACT:

Ms. Vicki Schneider, ITS Noesis Business Unit, 4100 N. Fairfax Drive, Suite 800, Arlington, VA 22203, 703-741-0300.

# SUPPLEMENTARY INFORMATION:

The mission of the Advisory Group is to provide advice to the Under Secretary of Defense for Acquisition, Technology and Logistics to the Director of Defense Research and Engineering (DDR&E), and through the DDR&E to the Director, Defense Advanced Research Projects Agency and the Military Departments in planning and managing an effective and economical research and development program in the area of electron devices.

The AGED meeting will be limited to review of research and development efforts in electronics and photonics with a focus on benefits to national defense. These reviews may form the basis for research and development programs initiated by the Military Departments and Defense Agencies to be conducted by industry, universities or in government laboratories. The agenda for this meeting will include programs on molecular electronics, microelectronics, electro-optics, and electronic materials. Due to unforeseen circumstances, this announcement does not give the standard 15-day notification.

In accordance with Section 10(d) of Pub. L. 92-463, as amended, (5 U.S.C. App. 2), it has been determined that this Advisory Group meeting concerns matters listed in 5 U.S.C. 552b(c)(1), and that accordingly, this meeting will be closed to the public.

Dated: November 21, 2006.

L.M. Bynum,

Alternate, OSD Federal Register Liaison Officer, Department of Defense.

[FR Doc. 06-9465 Filed 11-29-06; 8:45 am]

BILLING CODE 5001-06-M
[Crim. No. 601.

Fourth Appellate District.

October 10, 1941.]

#### THE PEOPLE, Respondent, v. GAIL WAITE, Appellant.

No appearance for Appellant.

Earl Warren, Attorney-General, and Eugene M. Elson, Deputy Attorney-General, for Respondent.

BARNARD, P. J.

The clerk’s transcript was filed in this court on May 15, 1940, and the reporter’s transcript on June 6, 1940. The cause was placed on the calendar on July 9, 1940, and continued to August 13, 1940, on which date the appellant was granted fifteen days in which to file an opening brief. No brief having been filed the cause was again placed on the calendar for October 8, 1940.  No appearance, by brief or otherwise, has been made on behalf of the appellant and when the cause was called on October 8, 1940, the attorney-general moved to affirm the judgment under the provisions of section 1253 of the Penal Code.

The motion is granted and the judgment affirmed.

Marks, J., and Griffin, J., concurred.
<TABLE> <S> <C>


<ARTICLE>                                            9
<LEGEND>
This schedule contains summary financial information from SEC Form 10-QSB and is
qualified in its entirety by reference to such financial information.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-START>                                 JAN-01-1999
<PERIOD-END>                                   MAR-31-1999
<CASH>                                             282
<INT-BEARING-DEPOSITS>                           1,008
<FED-FUNDS-SOLD>                                 3,900
<TRADING-ASSETS>                                     0 
<INVESTMENTS-HELD-FOR-SALE>                      6,371
<INVESTMENTS-CARRYING>                           6,371
<INVESTMENTS-MARKET>                             6,371
<LOANS>                                          1,430
<ALLOWANCE>                                         18
<TOTAL-ASSETS>                                  13,371
<DEPOSITS>                                       4,916
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                                 36
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         8,497
<OTHER-SE>                                        (337)
<TOTAL-LIABILITIES-AND-EQUITY>                  13,371
<INTEREST-LOAN>                                      7
<INTEREST-INVEST>                                  124
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                   131
<INTEREST-DEPOSIT>                                  25
<INTEREST-EXPENSE>                                  25
<INTEREST-INCOME-NET>                              106
<LOAN-LOSSES>                                       18
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                    282
<INCOME-PRETAX>                                   (188)
<INCOME-PRE-EXTRAORDINARY>                        (188)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (188)
<EPS-PRIMARY>                                    (0.20)
<EPS-DILUTED>                                    (0.20)
<YIELD-ACTUAL>                                    3.93
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                     0
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                   18
<ALLOWANCE-DOMESTIC>                                18
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        


</TABLE>
#### § 2522.320 [Reserved]
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 19

- 1285 V

UNPUBLISHED

BRENDA TATRO

, Trustee of the Sally J. Silver

Revocable Trust

Petitioner,

v.

SECRETARY OF HEALTH AND
HUMAN SERVICES,

Respondent. Chief Special Master Corcoran

Filed: September 28, 2021

Special Processing Unit (SPU) ;
Rul ing on Entitlement; Concession;
Table Injury; Influenza (Flu) Vaccine; Shoulder Injury Related to Vaccine Administration (SIRVA)

Christine M. Smith, Law Office of Christine M. Smith, Manchester, NH , for P etitioner.

Laurie Wiesner , U.S. Department of Justice, Washington, DC, for R espondent.

RULING ON ENTITLEMENT 1

On August 27, 2019

, Sally J. Silver 2 filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa

- 10, et seq. 3 (the “Vaccine Act”). Ms. Silver alleges that she suffered from a shoulder injury related to vaccine administration (“SIRVA”) after an influenza (“flu”) vaccination on September 14,

2017 . Petition at ¶ 1

. T he case was assigned to the Special Processing Unit of the Office of Special Masters.

1 Because this unpublished R uling contains a reasoned explanation for the action in this case, I am required
to post it on the United States Court of Federal Claims' website in accordance with the E

- Government Act

of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the R uling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that

the identified material f its within this definition, I will redact such material from public access.

2 On August 27 , 2020, Brenda Tatro, as Trustee of the Sally J. Silver Revocable Trust , was substituted as
petitioner after Ms. Silver passed away in March of 2020. ECF No. 22.

3 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99

- 660, 100 Stat. 3755

. Hereinafter, for ease
of citation, all section references to the Vaccine Act will be to the pertinent subpara graph of 42 U.S.C. § 300aa (2012 ).2 On September 27, 2021

, R espondent filed his Rule 4(c) report in which he

concedes that P etitioner is entitled to compensation in this case. Respondent’s Rule 4(c) Report at 1. Specifically, R espondent states that “Ms. Silver had no history of pain, inflammation, or dysfunction of her right shoulder prior to vaccination that would explain her signs, symptoms or findin gs after vaccination; the onset of pain occurred within 48 hours after receipt of an intramuscular vaccination; the pain was limited to the shoulder where the vaccine was administered; and no other condition or abnormality has been identified to explain Ms . Silver’s right shoulder symptoms

. ” Id. at 5

.

In view of R espondent’s position and the evidence of record, I find that

P etitioner is entitled to compensation.

IT IS SO ORDERED.

s/ Brian H. Corcoran

Brian H. Corcoran

Chief Special Master
Exhibit
32.1




ELEPHANT TALK
COMMUNICATIONS, INC.




CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350, AS ADOPTED PURSUANT TO




SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002









In connection with the Quarterly Report
of Elephant Talk Communications, Inc. (the “Company”) on Form 10-Q for the
period endingSeptember 30,
2010as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Steven
van der Velden, President and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge:




(1)           The Report fully complies with the
requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and




(2)           The information contained in the Report
fairly presents, in all material respects, the financial condition and result of
operations of the Company.




/s/
      Steven van der VeldenSteven
      van der VeldenPresident and Chief Executive
      Officer
                November 16,
      2010
#### Gould, appellant, v. Village of Phœnix.

*Debtor and creditor—payment of another’s debt without his request or recognition —Privity of contract.*

The plaintiff being president of a village, and acting in its behalf, employed M. to do certain work on the highway, for which the village was liable to pay. M. sued the plantiff for the work done, and a judgment by default being obtained against the plaintiff he paid it and brought his action against the village to recover back the amount. *Held,*that there was no privity of contract between the plaintiff and the village, and that the payment made to M. by the plaintiff, not having been made at the request of the village, or subsequently recognized by it, gave the plaintiff no right of action against the village. No one can make himself creditor of another by paying his debt without his request, or subsequent recognition of the act. *Stokes*v. *Lewis,*1 T. E. 20; *Taylor*v. *Baldwin,*10 Barb. 626; *Ingraham*v. *Gilbert,*20 id. 151.

Appeal from a judgment of the county court of Oswego county, reversing a judgment rendered in a justice’s court in favor of the plaintiff. The facts are sufficiently stated in the head-note.

*C. W. Avery,*for appellant.

*S. C. Huntington,*for respondent.

Gilbert, J.,

delivered the opinion of the court.

*Judgment affirmed.*
| 1. | The      Report fully complies with the requirements of section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|----|--------------------------------------------------------------------------------------------------------------------------------|

| 2. | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the      Company. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                         |   |                                                                                                                                                                              |
|------------------------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                         |   |                                                                                                                                                                              |
| Date:      May 14, 2009 | By:    | /s/  Neil      K.Warma                                                                                                          |
|                         |   | Neil      K. WarmaPresident      and Chief Executive Officer(Principal      Executive Officer)Acting      Chief Financial Officer(Principal      Financial and AccountingOfficer) |
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                             955
<INT-BEARING-DEPOSITS>                           1,000
<FED-FUNDS-SOLD>                                 6,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                      1,980
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                         21,170
<ALLOWANCE>                                        360
<TOTAL-ASSETS>                                  32,921
<DEPOSITS>                                      25,212
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                                188
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         3,325
<OTHER-SE>                                       4,196
<TOTAL-LIABILITIES-AND-EQUITY>                  32,927
<INTEREST-LOAN>                                    302
<INTEREST-INVEST>                                   14
<INTEREST-OTHER>                                   154
<INTEREST-TOTAL>                                   470
<INTEREST-DEPOSIT>                                 211
<INTEREST-EXPENSE>                                 211
<INTEREST-INCOME-NET>                              259
<LOAN-LOSSES>                                      108
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                    541
<INCOME-PRETAX>                                  (390)
<INCOME-PRE-EXTRAORDINARY>                       (390)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (390)
<EPS-BASIC>                                      (.59)
<EPS-DILUTED>                                        0
<YIELD-ACTUAL>                                    4.07
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                     0
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                    0
<ALLOWANCE-DOMESTIC>                               360
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
Exhibit 99.4



|     |  |                                                                              |  |                        |  |                                          
|---- |  | ---------------------------------------------------------------------------- |  | ---------------------- |  | -----------------------------------------
|LOGO |  | KPMG LLP Chartered Accountants 10125  102 Street Edmonton AB T5J 3V8 Canada |  | Telephone Fax Internet |  | (780) 429-7300 (780) 429-7379 www.kpmg.ca





CONSENT OF INDEPENDENT REGISTERED PUBLIC

ACCOUNTING FIRM



To the Board of Directors of North American Energy Partners Inc.



We consent to the inclusion in this annual report on Form 40-F of:



| | our Report of Independent Registered Public Accounting Firm dated June 8, 2009 on the consolidated balance sheets of North American Energy Partners Inc. (the Company) as at
March 31, 2009 and 2008, and the consolidated statements of operations, comprehensive (loss) income and deficit and cash flows for each of the years in three-year period ended March 31, 2009
|- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | our Report of Independent Registered Public Accounting Firm dated June 8, 2009 on the Companys internal control over financial reporting as of March 31, 2009
|- | --------------------------------------------------------------------------------------------------------------------------------------------------------------

each ofwhich is incorporated by reference in this annual report on Form 40-F of the Company for the fiscal year ended March 31,
2009.

LOGO

Chartered Accountants



Edmonton, Canada

June 8, 2009











| |  |                                                                                                                                                                                                                             |  |  |  | 
| |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  |  |  | 
| |  | KPMG LLP, is a Canadian limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International, a Swiss cooperative. KPMG
Canada provides services to KPMG LLP.
## U nit edSta tes C ou rt o f A pp eal s For t h e Firs t C ircu it

No. 06-2292 DAVID M. DUTIL, Petitioner, Appellant,

v . ROBERT MURPHY, Respondent, Appellee.

ERRATA SHEET The opinion of this Court issued on December 11, 2008 is amended as follows: On page 16, line 15: the word "hearing" is substituted for the word "trial" On page 16, line 18: the word "hearing" is substituted for the word "trial"
EXHIBIT
32.2








CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF
2002





In
connection with the Quarterly Report of Opexa Therapeutics, Inc. (the “Company”)
on Form 10-Q for the period ending March 31, 2008, (the “Report”), as filed
with the Securities and Exchange Commission on the date hereof, I, Lynne
Hohlfeld, Chief Financial Officer and Principal Accounting Officer of the
Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of
the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:




1.     The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and




2.     The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and   results of
      operations of the Company.











Date: May
13,
2008                                                          By:/s/Lynne
Hohlfeld


Lynne Hohlfeld


Chief
Financial Officer and Principal Accounting Officer
Exhibit 32(b)

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Alberto Culver Company (the company) for the
period ended September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Ralph J. Nicoletti, Senior Vice President and Chief Financial Officer of the company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                                                 
|-------------------------------------------------
|/s/ Ralph J. Nicoletti                           
|Senior Vice President and Chief Financial Officer

November 25, 2008
#### § 2507.12 Definitions for this subpart.

In addition to the definitions in § 2507.3, the following definitions apply to this subpart:

*Submitter* means any person or entity, including a corporation, State, or foreign government, but not including another Federal Government entity, that provides information, either directly or indirectly, to the Federal Government.

*Confidential commercial information* means commercial or financial information obtained by an agency from a submitter that may be protected from disclosure under Exemption 4 of the FOIA, 5 U.S.C. 552(b)(4).